Skip to main content
Journal cover image

Differences in COVID-19 screening, diagnosis, and hospitalization rates among US pregnant women with and without a substance use disorder.

Publication ,  Journal Article
Gao, YA; Jarlenski, MP; Chen, Q; Krans, EE
Published in: American journal of obstetrics and gynecology
October 2021

Duke Scholars

Published In

American journal of obstetrics and gynecology

DOI

EISSN

1097-6868

ISSN

0002-9378

Publication Date

October 2021

Volume

225

Issue

4

Start / End Page

450 / 451

Related Subject Headings

  • Young Adult
  • Substance-Related Disorders
  • SARS-CoV-2
  • Retrospective Studies
  • Pregnancy Complications
  • Pregnancy
  • Obstetrics & Reproductive Medicine
  • Humans
  • Hospitalization
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gao, Y. A., Jarlenski, M. P., Chen, Q., & Krans, E. E. (2021). Differences in COVID-19 screening, diagnosis, and hospitalization rates among US pregnant women with and without a substance use disorder. American Journal of Obstetrics and Gynecology, 225(4), 450–451. https://doi.org/10.1016/j.ajog.2021.06.004
Gao, Yitong Alice, Marian P. Jarlenski, Qingwen Chen, and Elizabeth E. Krans. “Differences in COVID-19 screening, diagnosis, and hospitalization rates among US pregnant women with and without a substance use disorder.American Journal of Obstetrics and Gynecology 225, no. 4 (October 2021): 450–51. https://doi.org/10.1016/j.ajog.2021.06.004.
Gao YA, Jarlenski MP, Chen Q, Krans EE. Differences in COVID-19 screening, diagnosis, and hospitalization rates among US pregnant women with and without a substance use disorder. American journal of obstetrics and gynecology. 2021 Oct;225(4):450–1.
Gao, Yitong Alice, et al. “Differences in COVID-19 screening, diagnosis, and hospitalization rates among US pregnant women with and without a substance use disorder.American Journal of Obstetrics and Gynecology, vol. 225, no. 4, Oct. 2021, pp. 450–51. Epmc, doi:10.1016/j.ajog.2021.06.004.
Gao YA, Jarlenski MP, Chen Q, Krans EE. Differences in COVID-19 screening, diagnosis, and hospitalization rates among US pregnant women with and without a substance use disorder. American journal of obstetrics and gynecology. 2021 Oct;225(4):450–451.
Journal cover image

Published In

American journal of obstetrics and gynecology

DOI

EISSN

1097-6868

ISSN

0002-9378

Publication Date

October 2021

Volume

225

Issue

4

Start / End Page

450 / 451

Related Subject Headings

  • Young Adult
  • Substance-Related Disorders
  • SARS-CoV-2
  • Retrospective Studies
  • Pregnancy Complications
  • Pregnancy
  • Obstetrics & Reproductive Medicine
  • Humans
  • Hospitalization
  • Female